Cite
HARVARD Citation
Wu, Z. et al. (2022). ROS-reactive PMS/PC drug delivery system improves new bone formation under diabetic conditions by promoting angiogenesis-osteogenesis coupling via down-regulating NOX2-ROS signalling axis. Biomaterials. p. . [Online].